Watanabe, S., Manabe, O., Hirata, K., Oyama-Manabe, N., Hattori, N., Kikuchi, Y., . . . Tamaki, N. (2016). The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD). BMC Cancer.

Watanabe, Shiro, Osamu Manabe, Kenji Hirata, Noriko Oyama-Manabe, Naoya Hattori, Yasuka Kikuchi, Kentaro Kobayashi, Takuya Toyonaga, und Nagara Tamaki. "The Usefulness of (18)F-FDG PET/CT for Assessing Methotrexate-associated Lymphoproliferative Disorder (MTX-LPD)." BMC Cancer 2016.

Watanabe, Shiro, et al. "The Usefulness of (18)F-FDG PET/CT for Assessing Methotrexate-associated Lymphoproliferative Disorder (MTX-LPD)." BMC Cancer 2016.